{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:02:15Z","timestamp":1770904935743,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T00:00:00Z","timestamp":1287532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Physiol Biochem"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s13105-010-0055-1","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T15:59:11Z","timestamp":1287503951000},"page":"115-120","source":"Crossref","is-referenced-by-count":8,"title":["Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis"],"prefix":"10.1007","volume":"67","author":[{"given":"Maha E.","family":"Houssen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona M.","family":"Haron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheren S.","family":"Metwally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,20]]},"reference":[{"key":"55_CR1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","volume":"20","author":"CC Allain","year":"1974","unstructured":"Allain CC, Poon LS, Chan CS, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470\u2013475","journal-title":"Clin Chem"},{"key":"55_CR2","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1093\/clinchem\/29.12.2026","volume":"29","author":"G Assmann","year":"1983","unstructured":"Assmann G, Schriewer H, Schmitz G, Hagele EO (1983) Quantification of high-density-lipoprotein cholesterol by precipitation with phosphotungstic acid\/MgCl2. Clin Chem 29:2026\u20132030","journal-title":"Clin Chem"},{"key":"55_CR3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0021-9150(98)00032-X","volume":"138","author":"M Aviram","year":"1998","unstructured":"Aviram M, Rosenblat M, Bisgaier CL, Newton RS (1998) Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. Atherosclerosis 138:271\u2013280","journal-title":"Atherosclerosis"},{"key":"55_CR4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/CVM-1-3-161","volume":"1","author":"GJ Blake","year":"2000","unstructured":"Blake GJ, Ridker PM (2000) Are statins anti-inflammatory? Curr Control Trials Cardiovasc Med 1:161\u2013165","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"55_CR5","first-page":"159","volume":"29","author":"GJ Broze Jr","year":"1992","unstructured":"Broze GJ Jr (1992) The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 29:159\u2013169","journal-title":"Semin Hematol"},{"key":"55_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0168-8227(93)90054-9","volume":"21","author":"A Ciampolillo","year":"1993","unstructured":"Ciampolillo A, Guastamacchia E, Caragiulo L, Lollino G, De Robertis O, Lattanzi V, Giorgino R (1993) In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients. Diabetes Res Clin Pract 21:87\u201393","journal-title":"Diabetes Res Clin Pract"},{"key":"55_CR7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00005344-199805000-00017","volume":"31","author":"A Corsini","year":"1998","unstructured":"Corsini A, Pazzucconi F, Arnaboldi L, Pfister P, Fumagalli R, Paoletti R, Sirtori CR (1998) Direct effects of statins on the vascular wall. J Cardiovasc Pharmacol 31:773\u2013778","journal-title":"J Cardiovasc Pharmacol"},{"key":"55_CR8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bmj.321.7255.199","volume":"321","author":"J Danesh","year":"2000","unstructured":"Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321:199\u2013204","journal-title":"BMJ"},{"key":"55_CR9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1600-6143.2005.00821.x","volume":"5","author":"MM Donners","year":"2005","unstructured":"Donners MM, Bot I, De Windt LJ, van Berkel TJ, Daemen MJ, Biessen EA, Heeneman S (2005) Low-dose FK506 blocks collar-induced atherosclerotic plaque development and stabilizes plaques in ApoE\u2212\/\u2212 mice. Am J Transplant 5:1204\u20131215","journal-title":"Am J Transplant"},{"key":"55_CR10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"55_CR11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1586\/14779072.5.2.345","volume":"5","author":"S Heeneman","year":"2007","unstructured":"Heeneman S, Donners MM, Bai L, Daemen MJ (2007) Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity? Expert Rev Cardiovasc Ther 5:345\u2013364","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"55_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0021-9150(92)90204-T","volume":"93","author":"R Hoffman","year":"1992","unstructured":"Hoffman R, Brook GJ, Aviram M (1992) Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies. Atherosclerosis 93:105\u2013113","journal-title":"Atherosclerosis"},{"key":"55_CR13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","volume":"97","author":"U Laufs","year":"1998","unstructured":"Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129\u20131135","journal-title":"Circulation"},{"key":"55_CR14","first-page":"203","volume":"44","author":"BG Madhumathi","year":"2006","unstructured":"Madhumathi BG, Venkataranganna MV, Gopumadhavan S, Rafiq M, Mitra SK (2006) Induction and evaluation of atherosclerosis in New Zealand white rabbits. Indian J Exp Biol 44:203\u2013208","journal-title":"Indian J Exp Biol"},{"key":"55_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-9150(98)00066-5","volume":"139","author":"T Matsumoto","year":"1998","unstructured":"Matsumoto T, Saito E, Watanabe H, Fujioka T, Yamada T, Takahashi Y, Ueno T, Tochihara T, Kanmatsuse K (1998) Influence of FK506 on experimental atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 139:95\u2013106","journal-title":"Atherosclerosis"},{"key":"55_CR16","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1161\/01.ATV.0000094234.60166.78","volume":"23","author":"R Murakami","year":"2003","unstructured":"Murakami R, Kambe F, Mitsuyama H, Okumura K, Murohara T, Niwata S, Yamamoto R, Seo H (2003) Cyclosporin A enhances interleukin-8 expression by inducing activator protein-1 in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 23:2034\u20132040","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"55_CR17","first-page":"222","volume":"9","author":"P Nachtigal","year":"2006","unstructured":"Nachtigal P, Jamborova G, Pospisilova N, Pospechova K, Solichova D, Zdansky P, Semecky V (2006) Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis. J Pharm Pharm Sci 9:222\u2013230","journal-title":"J Pharm Pharm Sci"},{"key":"55_CR18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1006\/cyto.1999.0488","volume":"11","author":"A Nakamura","year":"1999","unstructured":"Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T (1999) Effect of beta(2)-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. Cytokine 11:759\u2013765","journal-title":"Cytokine"},{"key":"55_CR19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1046\/j.1365-2249.2003.02021.x","volume":"131","author":"G Neurauter","year":"2003","unstructured":"Neurauter G, Wirleitner B, Laich A, Schennach H, Weiss G, Fuchs D (2003) Atorvastatin suppresses interferon-gamma-induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines. Clin Exp Immunol 131:264\u2013267","journal-title":"Clin Exp Immunol"},{"key":"55_CR20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0192-0561(96)00068-9","volume":"18","author":"S Niwa","year":"1996","unstructured":"Niwa S, Totsuka T, Hayashi S (1996) Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line. Int J Immunopharmacol 18:669\u2013675","journal-title":"Int J Immunopharmacol"},{"key":"55_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/153857440303700501","volume":"37","author":"D Pierre-Paul","year":"2003","unstructured":"Pierre-Paul D, Gahtan V (2003) Noncholesterol-lowering effects of statins. Vasc Endovasc Surg 37:301\u2013313","journal-title":"Vasc Endovasc Surg"},{"key":"55_CR22","first-page":"138","volume":"45","author":"LJ Powell","year":"1979","unstructured":"Powell LJ (1979) C-reactive protein\u2014a review. Am J Med Technol 45:138\u2013142","journal-title":"Am J Med Technol"},{"key":"55_CR23","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/hrt.2003.029785","volume":"91","author":"NM Rajamannan","year":"2005","unstructured":"Rajamannan NM, Subramaniam M, Stock SR, Stone NJ, Springett M, Ignatiev KI, McConnell JP, Singh RJ, Bonow RO, Spelsberg TC (2005) Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 91:806\u2013810","journal-title":"Heart"},{"key":"55_CR24","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1161\/01.CIR.0000038303.84249.4A","volume":"106","author":"S Rashid","year":"2002","unstructured":"Rashid S, Uffelman KD, Barrett PH, Lewis GF (2002) Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit. Circulation 106:2955\u20132960","journal-title":"Circulation"},{"key":"55_CR25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"PM Ridker","year":"2000","unstructured":"Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836\u2013843","journal-title":"N Engl J Med"},{"key":"55_CR26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI118174","volume":"96","author":"SE Roselaar","year":"1995","unstructured":"Roselaar SE, Schonfeld G, Daugherty A (1995) Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest 96:1389\u20131394","journal-title":"J Clin Invest"},{"key":"55_CR27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","volume":"86","author":"A Tedgui","year":"2006","unstructured":"Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86:515\u2013581","journal-title":"Physiol Rev"},{"key":"55_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0735-1097(99)00525-2","volume":"35","author":"CJ Vaughan","year":"2000","unstructured":"Vaughan CJ, Gotto AM Jr, Basson CT (2000) The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 35:1\u201310","journal-title":"J Am Coll Cardiol"},{"key":"55_CR29","first-page":"1824","volume-title":"Methods of enzyme analysis","author":"AW Wahlefeld","year":"1974","unstructured":"Wahlefeld AW (1974) Triglyceride determination after enzymatic hydrolysis. In: Bergmeyer HV (ed) Methods of enzyme analysis. Academic, New York, pp 1824\u20131831"},{"key":"55_CR30","first-page":"3272","volume":"23","author":"GD Wu","year":"1991","unstructured":"Wu GD, Cramer DV, Chapman FA, Cajulis E, Wang HK, Starzl TE, Makowka L (1991) FK 506 inhibits the development of transplant arteriosclerosis. Transplant Proc 23:3272\u20133274","journal-title":"Transplant Proc"}],"container-title":["Journal of Physiology and Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-010-0055-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13105-010-0055-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13105-010-0055-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T01:52:22Z","timestamp":1592013142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13105-010-0055-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,20]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["55"],"URL":"https:\/\/doi.org\/10.1007\/s13105-010-0055-1","relation":{},"ISSN":["1138-7548","1877-8755"],"issn-type":[{"value":"1138-7548","type":"print"},{"value":"1877-8755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,20]]}}}